Travere Therapeutics, Inc. Quarterly Goodwill in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Travere Therapeutics, Inc. quarterly Goodwill history and growth rate from Q1 2014 to Q2 2024.
  • Travere Therapeutics, Inc. Goodwill for the quarter ending June 30, 2024 was $800K, a 11.1% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $800K -$100K -11.1% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $800K -$100K -11.1% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $800K $0 0% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $800K -$100K -11.1% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $900K $0 0% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $900K $0 0% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $800K -$100K -11.1% Dec 31, 2022 10-K 2024-02-20
Q3 2022 $900K -$36K -3.85% Sep 30, 2022 10-Q 2022-10-27
Q2 2022 $900K -$36K -3.85% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $900K -$36K -3.85% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $900K $0 0% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $936K $0 0% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $936K $0 0% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $936K $0 0% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $900K -$36K -3.85% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $936K $0 0% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $936K $0 0% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $936K $0 0% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $936K $0 0% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $936K $0 0% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $936K $0 0% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $936K $0 0% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $936K $0 0% Dec 31, 2018 10-K 2020-02-24
Q3 2018 $936K $0 0% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $936K $0 0% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $936K $0 0% Mar 31, 2018 10-Q/A 2018-07-06
Q4 2017 $936K $0 0% Dec 31, 2017 10-K 2019-02-26
Q3 2017 $936K $0 0% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $936K $0 0% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $936K $0 0% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 $936K $0 0% Dec 31, 2016 10-K/A 2018-07-06
Q3 2016 $936K $0 0% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $936K $0 0% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $936K +$65.00 +0.01% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $936K $0 0% Dec 31, 2015 10-K 2017-03-01
Q3 2015 $936K +$65.00 +0.01% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $936K +$65.00 +0.01% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $936K -$100K -9.67% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $936K Dec 31, 2014 10-K 2016-02-26
Q3 2014 $936K Sep 30, 2014 10-Q 2014-11-13
Q2 2014 $936K Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $1.04M Mar 31, 2014 10-Q 2014-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.